Ming Tong Selected Research

3-Oxo-5-alpha-Steroid 4-Dehydrogenase (Testosterone 5 alpha Reductase)

11/2010	[V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].
12/2004	[Association of polymorphisms in testosterone 5-alpha-reductase II genotype and prognosis factors of prostate cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Tong Research Topics

Disease

27	Insulin Resistance 11/2020 - 09/2006
15	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 09/2006
12	Inflammation (Inflammations) 01/2022 - 08/2008
12	Fetal Alcohol Spectrum Disorders 07/2016 - 06/2007
11	Neoplasms (Cancer) 02/2022 - 12/2004
10	Fatty Liver 01/2022 - 01/2009
6	Cognitive Dysfunction 01/2017 - 01/2009
5	Carcinoma (Carcinomatosis) 01/2022 - 05/2002
5	COVID-19 01/2022 - 01/2020
5	Atrophy 12/2017 - 01/2012
5	Type 2 Diabetes Mellitus (MODY) 03/2010 - 09/2008
4	Fibrosis (Cirrhosis) 01/2022 - 01/2010
4	Prostatic Neoplasms (Prostate Cancer) 04/2019 - 12/2004
4	Alcoholism (Alcohol Abuse) 01/2016 - 09/2008
4	Hepatocellular Carcinoma (Hepatoma) 09/2015 - 08/2006
4	Mitochondrial Diseases (Mitochondrial Disease) 06/2012 - 06/2007
4	Obesity 01/2009 - 06/2004
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2022 - 01/2013
3	Dementia (Dementias) 01/2019 - 09/2006
3	Hypoxia (Hypoxemia) 12/2016 - 09/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 05/2002
3	Alcoholic Fatty Liver 12/2009 - 01/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2019
2	Long Term Adverse Effects 01/2022 - 01/2016
2	Bacterial Infections (Bacterial Infection) 10/2021 - 05/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2021 - 01/2021
2	Starvation 01/2021 - 01/2020
2	Brain Injuries (Brain Injury) 01/2020 - 07/2019
2	Neuroinflammatory Diseases 01/2019 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2009
2	Muscular Diseases (Myopathy) 01/2012 - 01/2012
1	Neoplasm Metastasis (Metastasis) 02/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Acute Lung Injury 08/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

32	Insulin (Novolin)FDA Link 01/2022 - 09/2006
22	Ethanol (Ethyl Alcohol)IBA 01/2022 - 06/2007
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2014
14	CeramidesIBA 02/2014 - 01/2009
13	LipidsIBA 01/2022 - 01/2009
12	NitrosaminesIBA 01/2020 - 01/2009
12	Insulin-Like PeptidesIBA 01/2019 - 08/2006
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2013
7	CytokinesIBA 01/2022 - 01/2009
7	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 08/2006
6	Insulin ReceptorIBA 01/2017 - 09/2008
5	SmokeIBA 07/2016 - 01/2016
4	Streptozocin (Streptozotocin)FDA Link 12/2019 - 01/2009
4	Nicotine FDA Link 01/2016 - 03/2015
4	KetonesIBA 01/2016 - 03/2015
3	thermozymocidin (myriocin)IBA 01/2022 - 10/2013
3	UbiquitinIBA 01/2019 - 01/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 06/2012
3	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2008 - 09/2006
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 12/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2019
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2021 - 05/2021
2	ApolipoproteinsIBA 11/2020 - 12/2019
2	EnzymesIBA 01/2020 - 11/2010
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	Jagged-1 ProteinIBA 01/2017 - 09/2010
2	Messenger RNA (mRNA)IBA 12/2016 - 07/2002
2	Aspartic Acid (Aspartate)FDA Link 12/2016 - 01/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2016 - 01/2016
2	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2016 - 09/2008
2	AcetylcholinesteraseIBA 11/2015 - 01/2012
2	3-nitrotyrosineIBA 11/2015 - 06/2012
2	Transcription Factors (Transcription Factor)IBA 11/2015 - 09/2010
2	Complementary DNA (cDNA)IBA 04/2015 - 05/2002
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2012 - 03/2011
2	3-Oxo-5-alpha-Steroid 4-Dehydrogenase (Testosterone 5 alpha Reductase)IBA 11/2010 - 12/2004
2	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 09/2010 - 05/2009
2	Small Interfering RNA (siRNA)IBA 09/2010 - 04/2009
2	Glycogen Synthase Kinase 3 betaIBA 06/2009 - 09/2008
1	LuciferinsIBA 02/2022
1	GoldIBA 02/2022
1	InflammasomesIBA 01/2022
1	Cycloheximide (Cicloheximide)IBA 01/2022
1	Serine C-PalmitoyltransferaseIBA 01/2022
1	InterleukinsIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	STAT1 Transcription FactorIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 08/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	5-methoxytryptophanIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Serum-Free Culture MediaIBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	GuanosineIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Peptides (Polypeptides)IBA 11/2020
1	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 01/2020

Therapy/Procedure

3	Therapeutics 06/2019 - 10/2009
1	Injections 02/2022
1	Photothermal Therapy 02/2022